Rizatriptan
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 501 publications
Migraine attack therapy: from new efficacy criteria to novel therapeutic formulations
Journal: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
Published: June 05, 2026
Eco-friendly appraised HPTLC strategy for the simultaneous determination of the newly approved meloxicam and rizatriptan mixture in their formulation.
Journal: Journal of chromatography. B, Analytical technologies in the biomedical and life sciences
Published: February 25, 2026
A neural substrate for targeted analgesia associated with attenuated serotonergic transmission in a mouse model of medication overuse headache.
Journal: The journal of headache and pain
Published: January 04, 2026
Intranasal hybrid nanoparticles encapsulating rizatriptan enhance antimigraine efficacy in an optogenetic spreading depression model.
Journal: International journal of pharmaceutics
Published: December 12, 2025
Serotonin Syndrome With Quetiapine, Rizatriptan, Gabapentin, and Propranolol.
Journal: The primary care companion for CNS disorders
Published: December 10, 2025
Sex differences in cluster headache: insights from the Chinese Cluster Headache Register Individual Study (CHRIS).
Journal: The journal of headache and pain
Published: December 01, 2025
Measurement and modeling of rizatriptan in supercritical CO2 for pharmaceutical processing.
Journal: Scientific reports
Published: September 05, 2025
A comparison of the persistence of acute treatment with rimegepant versus oral triptans in patients with migraine: A retrospective analysis of US claims data.
Journal: Cephalalgia : an international journal of headache
Published: July 28, 2025
A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy.
Journal: Journal of pain research
Published: July 04, 2025
Meloxicam and Rizatriptan Benzoate.
Journal: American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
Published: June 25, 2025
Rizatriptan vs Placebo for Attacks of Vestibular Migraine: A Randomized Clinical Trial.
Journal: JAMA neurology
Published: May 12, 2025
Neuroinflammatory crosstalk in migraine: consolidated activity of rizatriptan and meloxicam in suppressing CGRP-induced nociception and COX-mediated inflammation.
Journal: Inflammopharmacology
Published: May 07, 2025
Last Updated: 06/30/2026